1. Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma
   Ji-Zhong Yin et al, 2023, International Immunopharmacology CrossRef
2. Metal Drugs and the Anticancer Immune Response
   Bernhard Englinger et al, 2019, Chemical Reviews CrossRef
3. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias
   Saghar Yousefnia, 2021, Cell Biology International CrossRef
4. Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors
   Rabab El Eit et al, 2019, Cancer CrossRef
5. A candidate for lung cancer treatment: arsenic trioxide
   W. Huang et al, 2019, Clinical and Translational Oncology CrossRef
6. Combination therapy: Future directions of immunotherapy in small cell lung cancer
   Wei Huang et al, 2021, Translational Oncology CrossRef
7. Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy
   Daan F. Boreel et al, 2021, Clinical Cancer Research CrossRef
8. Alterations in Microbial-Associated Fecal Metabolites in Relation to Arsenic Exposure Among Infants
   Margaret R. Karagas et al, 2022, Exposure and Health CrossRef
9. The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
   Jun-Zhu Chen et al, 2023, Frontiers in Oncology CrossRef
10. Macrophage secretory IL-1β promotes docetaxel resistance in head and neck squamous carcinoma via SOD2/CAT-ICAM1 signaling
    Ching-Yun Hsieh et al, 2022, JCI Insight CrossRef
11. The application of arsenic trioxide in cancer: An umbrella review of meta-analyses based on randomized controlled trials
    Jixin Chen et al, 2023, Journal of Ethnopharmacology CrossRef
12. PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy
    Liangdi Jiang et al, 2023, Biomaterials Science CrossRef